Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma

Anticancer Research

Volumn 18, Issue 5 B, 1998, Pages 3651-3656

  Tsuchiya, Hiroyuki ^a   Tomita, Katsuro ^a   Yamamoto, Norio ^a   Mori, Yoshihiko ^a   Asada, Naohiro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Caffeine; Chemotherapy; Limb sparing surgery; Soft tissue sarcoma; Survival

Indexed keywords

CAFFEINE; CISPLATIN; DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHONDROSARCOMA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENTIATION; EPITHELIOID SARCOMA; FEMALE; FOLLOW UP; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LEIOMYOSARCOMA; LIPOSARCOMA; LUNG METASTASIS; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT NEURILEMOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAFFEINE; COMBINED MODALITY THERAPY; DRUG SYNERGISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031647553     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Eilber FR and Rosen G: Adjuvant chemotherapy for osteosarcoma. Semin Oncol 4: 312-323, 1989.
2. Jürgens H, Exner U, Gadner H, et al: Multidisciplinary treatment of primary Ewing' s sarcoma of bone. A 6-year experience of a European cooperative trial. Cancer 61: 23-32, 1988.
3. Boring CC, Squires TS, Tong T, et al: Cancer statistics, 1994. Ca Cancer J Clin 44: 7-26, 1994.
4. Gaynor JJ, Tan CC, Casper ES, et al: Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 10: 1317-1327, 1992.
5. Cohen M, Schoenfeld D and Wolter J: Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma. Cancer Treat Rep 64: 151-153, 1980.
6. Stewart DJ, Benoit B, Hugenholtz H, et al: Cisplatin, arabinofuranosylcytosine and caffeine before radiation for glioblastomas. In: Biology of Brain Tumors, Walker MD, Thomas DT (eds), Boston, Martinus Nijhoff, pp393-398, 1986.
7. Kelsen D, Hudis C, Niedzwiecki D, et al: A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma. Cancer 68: 965-969, 1991.
8. Tsuchiya H, Yasutake H, Yokogawa A, et al: Effect of chemotherapy combined with caffeine for osteosarcoma. J Cancer Res Clin Oncol 118: 567-569, 1992.
9. Tomita K and Tsuchiya H: Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn J Cancer Res 80: 83-88, 1989.
10. Yasutake H, Tsuchiya H, Tomita K, et al: Inhibitory effect of caffeine on potentially lethal damage repair in cisplatin-treated human osteosarcoma cells. Anticancer Res 15: 831-838, 1995.
11. Tomita K and Tsuchiya H: Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma. Clin Ther 11: 43-52, 1989.
12. Tsuchiya H, Tomita K, Yasutake H, et al: Intra-arterial cisplatin and caffeine with/without doxorubicin for musculoskeletal high-grade spindle cell sarcoma. Oncology Rep 1: 27-36, 1994.
13. Enneking WF. A system for the functional evaluation of the surgical management of musculoskeletal tumors. In: Enneking WF (ed), Limb salvage in musculoskeletal oncology. Edinburgh: Churchill Livingstone, pp 5-16, 1987.
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
15. Rosenberg SA, Kent H, Costa J, et al: Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemotherapy in the treatment of adult soft-tissue sarcoma. Surgery 84: 62-69, 1978.
16. Das Gupta TK, Patel MK, Chauduri PK, et al: The role of chemotherapy as an adjuvant to surgery in the initial treatment of primary soft tissue sarcomas in adults. J Surg Oncol 19: 139-144,1982.
17. Antman K, Ryan L, Borden E, et al: Pooled results from three randomized adjuvant studies of doxorubicin versus observation in soft tissue sarcoma: 10-year results and review of the literature. In: Salmon SE (ed), Adjuvant therapy of cancer VI., Philadelphia, WB Saunders, pp 529-543, 1990.
18. Casper ES: Adjuvant chemotherapy of soft tissue sarcomas. In: Economou SG, Witt TR, Deziel DJ, Saclarides TJ, Staren ED, Bines S (ed), Adjuncts to cancer surgery, Philadelphia, Lea and Febiger, pp 490-494, 1991.
19. Benjamin RS, Terjanian TO, Fenoglio CJ, et al: The importance of combination chemotherapy for adjuvant treatment of high-risk patients with soft-tissue sarcomas of the extremities. In: Salmon SE (ed), Adjuvant therapy of cancer V., Orlando, Grune and Stratton, pp 735-744, 1987.
20. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221-1230, 1982.
21. Byfield JE, Muranee J, Ward JF, et al: Mice, men, mustards and methylated xanthines: The potential role of caffeine and related drugs in the sensitization of human tumors to alkylating agents. Br J Cancer 43: 669-682, 1981.
22. Tsuchiya H, Tomita K, Mori Y, et al: Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res 18: 657-666, 1998.
23. Tsuchiya H, Tomita K, Minematsu K, et al: Limb salvage using distraction osteogenesis. J Bone Joint Surg 79-B: 403-411, 1997.
24. Eggermont AMM, Koops HS, Lienard D, et al: Isolated limb perfusion with high-dose tumor necrosis factor-a in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 14: 2653-2665, 1996.
25. Gutman M, Inbar M, Lev-Shlush D, et al: High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 79: 1129-1137, 1997.
26. Casper ES, Gaynor JJ, Harrison LB, et al: Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 73: 1644-1651, 1994.
27. Enneking WF: A system of staging musculoskeletal neoplasms. Clin Orthop 204: 9-24, 1986.